全球研发投资10强企业

    8. 强生

    • 2013年研发支出：82亿美元

    • 占收入的百分比：11.5%

    长期以来，研发投资一直让这家美国医疗保健公司引以为豪。在过去五年中，强生也一直是制药行业研发投入最多的企业之一。这些投资已经带来了高额回报——2009年以来，强生的制药业务已推出14种新药。强生表示，该公司计划在2013-2017年推出十多种新药和25种延伸产品。

    8. Johnson & Johnson

    • R&D spending in 2013: $8.2 billion

    • As a percentage of revenue: 11.5%

    The American health care company has long prided itself on investing in R&D and for the past five years has consistently been among the top spenders in the pharma industry. That investment has paid off big, with the pharmaceutical business launching 14 new compounds since 2009. J&J says it plans to file more than 10 new drugs and 25 line extensions between 2013 and 2017.